Cargando…
Small molecule glucagon release inhibitors with activity in human islets
PURPOSE: Type 1 diabetes (T1D) accounts for an estimated 5% of all diabetes in the United States, afflicting over 1.25 million individuals. Maintaining long-term blood glucose control is the major goal for individuals with T1D. In T1D, insulin-secreting pancreatic islet β-cells are destroyed by the...
Autores principales: | Kalwat, Michael A., Rodrigues-dos-Santos, Karina, Binns, Derk D., Wei, Shuguang, Zhou, Anwu, Evans, Matthew R., Posner, Bruce A., Roth, Michael G., Cobb, Melanie H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157210/ https://www.ncbi.nlm.nih.gov/pubmed/37152965 http://dx.doi.org/10.3389/fendo.2023.1114799 |
Ejemplares similares
-
α(2)-Adrenergic Disruption of β Cell BDNF-TrkB Receptor Tyrosine Kinase Signaling
por: Kalwat, Michael A., et al.
Publicado: (2020) -
Axon Guidance Molecules in the Islets of Langerhans
por: Waters, Bayley J., et al.
Publicado: (2022) -
The Pancreatic ß-cell Response to Secretory Demands and Adaption to Stress
por: Kalwat, Michael A, et al.
Publicado: (2021) -
Role of Exosomes in Islet Transplantation
por: Mattke, Jordan, et al.
Publicado: (2021) -
Signaling mechanisms of glucose-induced F-actin remodeling in pancreatic islet β cells
por: Kalwat, Michael A, et al.
Publicado: (2013)